Personalized GI Motility Responses to Diet

Purpose

The goal of this randomized, crossover, clinical trial is to link: 1) gastrointestinal motility patterns induced by acute consumption of whole and refined grains, 2) enteric microbial production of bioactive metabolites, and 3) circulating postprandial appearance of metabolites important to cardiometabolic health including glucose, triglycerides, and cholesterol. Participants will be asked to consume a Smartpill monitoring device that records metrics of gastrointestinal motility in response to whole or refined grains, monitor cardiometabolic metabolties over an 8 hour postprandial window, and provide a fecal sample for microbiome-related analyses.

Conditions

  • Nutritional and Metabolic Diseases
  • Gastrointestinal Dysfunction
  • Cardiovascular Diseases
  • Dysbiosis

Eligibility

Eligible Ages
Between 21 Years and 63 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy men and women

Exclusion Criteria

Physician-Diagnosed: - Diabetes Mellitus - Nutrient-malabsorption disorders - Intestinal Bowel Syndrome (IBS) - Intestinal Bowel Disease (IBD) - Bleeding-related disorders - Grain allergy - Psychological Disorders - Stenosis - Dysphasia History of: - Bariatric Surgery - Gallbladder removal - Eating disorders - Antibiotic administration (within the past three months) - Hormone therapy Currently: - Using statins - Pregnant, lactating, or postmenopausal - Taking oral hypoglycemic agents or insulin - Ingesting prescription fiber - Using cholesterol and bile acid absorption inhibitors - Ingesting nutrition supplements, not including a daily multivitamin (i.e. herbs, tinctures, and extracts) •Using recreational drugs or alcohol (within the past week) - Taking anti-histamines - Taking proton pump inhibitors - Taking antacids

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Intervention Model Description
Randomized, controlled, crossover
Primary Purpose
Basic Science
Masking
None (Open Label)
Masking Description
Appearance, flavor, and texture of whole grain vs refined bread could not be masked

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Whole grain rye bread
4.3 ounces of whole grain rye bread, consumed after an overnight fast (12+ hours)
  • Other: Whole grain rye bread
    Single consumption of 4.3 oz of whole grain rye bread
Placebo Comparator
Refined grain rye bread
4.3 ounces of white rye bread, consumed after an overnight fast (12+ hours)
  • Other: Refined grain rye bread
    Single consumption of 4.3 oz of refined grain rye bread

Recruiting Locations

University of Illinois at Urbana-Champaign
Urbana, Illinois 61801
Contact:
Brett R Loman, PhD, RD

More Details

NCT ID
NCT06386471
Status
Recruiting
Sponsor
University of Illinois at Urbana-Champaign

Study Contact

Brett R Loman, PhD, RD
217-333-3451
bloman2@illinois.edu